U.S. public transportation agencies have faced numerous challenges since the onset of the COVID-19 pandemic, with the rise in drug use on transit systems being one of the most visible, pressing, and complex. The primary goal of this report is to document and synthesize the current practices of transit agencies in addressing the consumption and distribution of illegal drugs on their systems, as well as the resulting effects on customer and staff safety and security. Program and policy responses for the following five participating transit agencies were documented:
This synthesis begins with a literature review to present an overview of drug use on transit systems and examine how various transit agencies have responded. The synthesis then presents findings from in-person agency visits and staff interviews, along with a review of information and data provided by the five participating agencies. The synthesis concludes by identifying challenges, areas of opportunity, and knowledge gaps in the agencies’ responses to this issue.
The literature review analyzed transit agencies’ responses to drug use issues as detailed in academic publications and agency materials. These sources revealed three main themes:
Five case example agencies were selected to provide the report with a diverse set of programmatic, outreach, and enforcement responses to the issue. Criteria used to select the five case examples included variation in regulatory responses, geographic diversity, varied transit infrastructure and modes, varied climates, evidence of existing program responses, and willingness to participate in this study.
Data related to drug use and safety were requested and received from all five agencies. However, data collection and reporting across the participating agencies are inconsistent—some data sources are specific to each agency and their associated outreach and law enforcement partners. The data are organized into the following five categories:
Highlights from each of the five participating agencies’ program responses to drug use on their systems follow:
Findings (from the literature review, data analysis, interviews with transit agency staff, and in-person ridealongs with outreach partners and law enforcement across five transit agencies) are organized into challenges, opportunities, and knowledge gaps.
On transit systems across the United States, rising rates of drug use along with deteriorating safety conditions for customers and staff have become increasingly pressing and complex issues for transit agencies to solve. Many challenges surround agencies’ responses to drug use on transit, such as inconsistent data collection and the low uptake of support services (which results from various causes, including inadequate available support). Many opportunities exist for agencies to improve how they handle drug use on their systems, such as standardizing naloxone deployment policies and implementing CPTED design principles to improve safety.
Although this synthesis focused on analyzing current practices by transit agencies in responding to drug use on their systems, further research, such as the relationship between fare enforcement and safety, would be useful to better understand and address this deeply complex societal issue.